首页> 外文期刊>The biochemical journal >The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases
【24h】

The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases

机译:在戈登高血压综合征中突变的WNK1和WNK4蛋白激酶磷酸化并激活SPAK和OSR1蛋白激酶

获取原文
           

摘要

pMutations in the human genes encoding WNK1 [with no K (lysine) protein kinase-1] and the related protein kinase WNK4 are the cause of Gordon9s hypertension syndrome. Little is known about the molecular mechanism by which WNK isoforms regulate cellular processes. We immunoprecipitated WNK1 from extracts of rat testis and found that it was specifically associated with a protein kinase of the STE20 family termed ‘STE20/SPS1-related proline/alanine-rich kinase’ (SPAK). We demonstrated that WNK1 and WNK4 both interacted with SPAK as well as a closely related kinase, termed ‘oxidative stress response kinase-1’ (OSR1). Wildtype (wt) but not catalytically inactive WNK1 and WNK4 phosphorylated SPAK and OSR1 to a much greater extent than with other substrates utilized previously, such as myelin basic protein and claudin-4. Phosphorylation by WNK1 or WNK4 markedly increased SPAK and OSR1 activity. Phosphopeptide mapping studies demonstrated that WNK1 phosphorylated kinase-inactive SPAK and OSR1 at an equivalent residue located within the T-loop of the catalytic domain (Thrsup233/sup in SPAK, Thrsup185/sup in OSR1) and a serine residue located within a C-terminal non-catalytic region (Sersup373/sup in SPAK, Sersup325/sup in OSR1). Mutation of Thrsup185/sup to alanine prevented the activation of OSR1 by WNK1, whereas mutation of Thrsup185/sup to glutamic acid (to mimic phosphorylation) increased the basal activity of OSR1 over 20-fold and prevented further activation by WNK1. Mutation of Sersup325/sup in OSR1 to alanine or glutamic acid did not affect the basal activity of OSR1 or its ability to be activated by WNK1. These findings suggest that WNK isoforms operate as protein kinases that activate SPAK and OSR1 by phosphorylating the T-loops of these enzymes, resulting in their activation. Our analysis also describes the first facile assay that can be employed to quantitatively assess WNK1 and WNK4 activity./p
机译:>编码WNK1 [无K(赖氨酸)蛋白激酶-1]和相关蛋白激酶WNK4的人类基因突变是Gordon9s高血压综合征的病因。关于WNK亚型调节细胞过程的分子机制知之甚少。我们从大鼠睾丸提取物中免疫沉淀了WNK1,发现它与STE20家族的蛋白激酶(称为“ STE20 / SPS1相关的脯氨酸/富含丙氨酸的激酶”)(SPAK)特别相关。我们证明WNK1和WNK4都与SPAK以及密切相关的激酶(称为“氧化应激反应激酶1”(OSR1))相互作用。野生型(wt),而不是无催化活性的WNK1和WNK4使SPAK和OSR1磷酸化的程度比以前使用的其他底物(如髓鞘碱性蛋白和claudin-4)高得多。 WNK1或WNK4的磷酸化显着增加了SPAK和OSR1的活性。磷酸肽图研究表明,WNK1磷酸化了激酶失活的SPAK和OSR1,位于催化域(SPAK中的Thr 233 ,Thr 185 OSR1)和位于C端非催化区域(SPAK中的Ser 373 ,OSR1中的Ser 325 )内的丝氨酸残基。将Thr 185 突变为丙氨酸可阻止WNK1激活OSR1,而将Thr 185 突变为谷氨酸(以模拟磷酸化作用)可提高OSR1的基础活性超过20-折叠并阻止了WNK1的进一步激活。 OSR1中Ser 325 突变为丙氨酸或谷氨酸不会影响OSR1的基础活性或被WNK1激活的能力。这些发现表明,WNK同工型作为蛋白激酶起作用,通过使这些酶的T环磷酸化来激活SPAK和OSR1,从而激活它们。我们的分析还描述了第一个可用于定量评估WNK1和WNK4活性的简便测定方法。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号